Statistics
Publications
9
Citations
597
H-Index
9
Active since
2010
F. Ravandi Kashani is an author at Johannes Gutenberg University Mainz specializing in medicine, endothelial dysfunction, and inflammation.
Publications per year
2010–2018
9
9
The SGLT2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats
Sebastian Steven, Matthias Oelze, Alina Hanf et al. · Redox Biology · 2017 · 305 citations · Full text
Sebastian Steven, Kerstin Jurk, Maximilian Kopp et al. · British Journal of Pharmacology · 2016 · 101 citations · Full text
Medicine, Immunology, Pharmacology +17
Sebastian Steven, Mobin Dib, Michael Hausding et al. · Cardiovascular Research · 2017 · 51 citations · Full text
Sebastian Steven, Mobin Dib, Siyer Roohani et al. · International Journal of Molecular Sciences · 2017 · 38 citations · Full text
1–5 of 9